OKYO Pharma (OKYO)

Currency in USD
2.060
-0.040(-1.90%)
Closed·
2.020-0.040(-1.94%)
·
OKYO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.0102.120
52 wk Range
0.9023.349
Key Statistics
Prev. Close
2.1
Open
2.08
Day's Range
2.01-2.12
52 wk Range
0.902-3.349
Volume
34.08K
Average Volume (3m)
150.56K
1-Year Change
94.34%
Book Value / Share
-0.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OKYO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.333
Upside
+304.53%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

OKYO Pharma News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

OKYO Pharma Ltd Company Profile

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase II clinical trials for the treatment of dry eye disease; in Phase II clinical trial to treat neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201 for the treatment acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Employees
4

Compare OKYO to Peers and Sector

Metrics to compare
OKYO
Peers
Sector
Relationship
P/E Ratio
−16.5x−4.4x−0.6x
PEG Ratio
−0.210.180.00
Price/Book
−14.0x3.9x2.6x
Price / LTM Sales
-15.9x3.2x
Upside (Analyst Target)
233.3%209.8%41.8%
Fair Value Upside
Unlock3.1%5.1%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 8.333
(+304.53% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
B.Riley
Buy5.00+142.72%-New Coverage07/12/2025
H.C. Wainwright
Buy7.00+239.81%-Maintain23/09/2025
Lucid Capital Markets
Buy13.00+531.07%-New Coverage31/07/2025
H.C. Wainwright
Buy7.00+239.81%-Maintain17/07/2025
H.C. Wainwright
Buy7.00+239.81%-Maintain18/02/2025

Earnings

Latest Release
Dec 03, 2025
EPS / Forecast
-0.02 / -0.04
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

0.43
WGRX
-8.56%
9.22
ENGN
+5.13%
1.27
CTOR
+1.60%
2.430
CMND
-6.18%
5.670
IMMX
-2.41%

FAQ

What Is the OKYO Pharma Ltd (OKYO) Share Price Today?

The live OKYO Pharma Ltd share price today is 2.060

What Stock Exchange Does OKYO Pharma Ltd (OKYO) Trade On?

OKYO Pharma Ltd is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for OKYO Pharma Ltd?

The stock symbol (also called a 'ticker') for OKYO Pharma Ltd is "OKYO."

What Is the Current OKYO Pharma Ltd Market Cap?

As of today, OKYO Pharma Ltd market capitalisation is 77.48M.

What Is OKYO Pharma Ltd's (OKYO) Earnings Per Share (TTM)?

The OKYO Pharma Ltd EPS is currently -0.12 (Trailing Twelve Months).

When Is the Next OKYO Pharma Ltd Earnings Date?

OKYO Pharma Ltd's next earnings report will be released on 25 Feb 2026.

Is OKYO a Buy or Sell From a Technical Analyst Perspective?

Based on today's OKYO Pharma Ltd moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has OKYO Pharma Ltd Stock Split?

OKYO Pharma Ltd has split 2 times. (See the OKYO stock split history page for full effective split date and price information.)

How Many Employees Does OKYO Pharma Ltd Have?

OKYO Pharma Ltd has 4 employees.

What is the current trading status of OKYO Pharma Ltd (OKYO)?

As of 24 Dec 2025, OKYO Pharma Ltd (OKYO) is trading at a price of 2.060, with a previous close of 2.100. The stock has fluctuated within a day range of 2.010 to 2.120, while its 52-week range spans from 0.902 to 3.349.

What Is OKYO Pharma Ltd (OKYO) Price Target According to Analysts?

The average 12-month price target for OKYO Pharma Ltd is USD8.33333, with a high estimate of USD13 and a low estimate of USD5. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +304.53% Upside potential.

What Is the OKYO Premarket Price?

OKYO's last pre-market stock price is 2.051. The pre-market share volume is 180.000, and the stock has decreased by -0.049, or -2.330%.

What Is the OKYO After Hours Price?

OKYO's last after hours stock price is 2.020, the stock has decreased by -0.040, or -1.940%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.